Kidney Dis (Basel) 6:395406 Adema AY, de Roij van Zuijdewijn CLM, Hoenderop JG, de Borst MH, Ter Wee PM, Heijboer AC, Vervloet MG, NIGRAM consortium (2018) Influence of exogenous growth hormone administration on circulating concentrations of -klotho in healthy and chronic kidney disease subjects: a prospective, single-center open case-control pilot study
Among these, CJC-1295 stands out as a synthetic analog of Growth Hormone-Releasing Hormone (GHRH)
For patients without neurological involvement, the initial regimen is typically 1 mg intramuscularly three times weekly for 2 weeks
Impairment of clinical neurovascular coupling is considered one cause of cognitive impairment
Linarine exhibits potential effects in DED in vivo, as it extended tear film rupture time, increased tear secretion, and facilitated corneal damage healing
October 30, 2025 supplements for arthritis